Circulating levels of tumour necrosis factor-α and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis

[1]  R. Ferrari,et al.  Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-alpha. , 1999, European heart journal.

[2]  M. Bellomo,et al.  Tumor necrosis factor is increased in the spinal cord of an animal model of motor neuron degeneration. , 1998, European cytokine network.

[3]  R. Ransohoff.  Chemokines in neurological disease models: correlation between chemokine expression patterns and inflammatory pathology , 1997, Journal of leukocyte biology.

[4]  L. Colom,et al.  Autoimmunity and ALS , 1996, Neurology.

[5]  D. Aderka.  The potential biological and clinical significance of the soluble tumor necrosis factor receptors. , 1996, Cytokine & growth factor reviews.

[6]  David W. Anderson,et al.  Altered expression of bcl‐2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons , 1996, Annals of neurology.

[7]  B. Gazzard,et al.  Aids-associated vacuolar myelopathy and tumor necrosis factor-alpha (TNFα) , 1996, Journal of Neurological Sciences.

[8]  E. Stefani,et al.  Altered muscle calcium channel binding kinetics in autoimmune motoneuron disease , 1995, Muscle & nerve.

[9]  B. Brooks,et al.  El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.

[10]  M. Schwartz,et al.  Tumor necrosis factor facilitates regeneration of injured central nervous system axons , 1991, Brain Research.

[11]  S. Appel,et al.  IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. , 1990, Archives of neurology.

[12]  T. Espevik,et al.  A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. , 1986, Journal of immunological methods.

[13]  M. Gurney,et al.  Inhibition of terminal axonal sprouting by serum from patients with amyotrophic lateral sclerosis. , 1984, The New England journal of medicine.

[14]  F. Norris,et al.  The administration of guanidine in amyotrophic lateral sclerosis , 1974, Neurology.

[15]  P. Vassalli,et al.  The pathophysiology of tumor necrosis factors. , 1992, Annual review of immunology.